Federal appeals court judges upheld a lower court’s ruling preventing the NIH from cutting billions of dollars in support for ...

David Mitchell, who helped launch Patients for Affordable Drugs to raise awareness of high drug prices and seek to bring them ...

WASHINGTON — Federal health officials are unilaterally reducing the number of recommended pediatric immunizations in response ...

Neuralink, a leader in the fledgling field of brain implants, is hurting the industry's efforts to develop useful medical ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

When Americans make decisions — like whether to pack an umbrella or prepare for a hurricane — they rely on clear, timely, and ...

ATLATL, one of China’s leading biotech incubators, is seeking to bridge East-West innovation and tap into China's rapidly ...

Argenx CEO Tim Van Hauwermeiren is stepping down in May and will be succeeded by Karen Massey, the Belgian drugmaker's COO.

Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per ...

We have plenty of fresh coverage to start the week. We can also report that our upcoming STAT@JPM event — featuring Richard ...

The debate over paying for AI will intensify as more devices enter the field, STAT’s Katie Palmer reports. The FDA has ...

A new year always brings new challenges, and there will be many challenges facing the pharmaceutical industry and policymakers in 2026 as Americans continue to clamor for affordable medicines that ...